Search results
Author(s):
Marianne Brodmann
Added:
5 months ago
ISET 2025 - How have drug delivery devices changed over the years, and what are the novel technologies and therapeutic agents?Dr Marianne Brodmann (Medical University of Graz, AT) joins us onsite at ISET 2025 to discuss the current landscape of drug delivery devices, from paclitaxel drug-coated balloons to drug-eluting stents. Dr Brodmann discusses evolving technologies, including bioresorbable…
View more
Author(s):
Luca Paolucci
,
Asad Shabbir
,
Marco Lombardi
,
et al
Added:
6 months ago
Author(s):
Arditya Damarkusuma
,
Paula Mota
,
Billal Patel
,
et al
Added:
1 year ago
Author(s):
Marianne Brodmann
Added:
5 months ago
LINC 2025 - 12-month amputation and readmission rates from the TRUE-PTX study suggests endovascular revascularisation for peripheral artery disease (PAD) with drug-eluting devices lead to better outcomes than with bare device therapies.Dr Marianne Brodmann (Medical University of Graz, AT) joins us to discuss the TRUE-PTX study evaluating a database of patients in the US with PAD who have recieved…
View more
Author(s):
Alfonso Ielasi
Added:
2 years ago
This video features Dr Alfonso Ielasi (IRCCS Ospedale Galeazzi Sant'Ambrogio, Milano, IT) presenting a dynamic poster focused on the 2-Year Follow-up of a Hybrid Strategy for Diffuse Coronary Artery Disease (CAD).He highlights the challenging nature of de novo diffuse coronary artery disease (CAD) in interventional cardiology, where limited treatment options exist beyond stent implantation.To…
View more
Author(s):
Viktor Sasi
,
Gyula Szántó
,
Alexandru Achim
,
et al
Added:
1 year ago
AF, Stent and Anticoagulant
Author(s):
Balen Abdulrahman
,
Richard J Jabbour
,
Nick Curzen
Added:
2 years ago
Article
Author(s):
Arditya Damarkusuma
Added:
1 year ago
In this video, Dr Arditya Damarkusuma (Universitas Gadjah Mada, ID) presents his case report on aorto-ostial lesions, recently published in ICR Journal.This case covers the restenosis of a markedly protruding stent at the right coronary ostium in a 54-year old man, and is unusual in its 10-year longevity. Intravascular ultrasound-guided in-stent restenosis intervention using a wire bumper…
View more
Author(s):
Roxana Mehran
Added:
1 year ago
EuroPCR 24 - Dr Roxana Mehran (Mount Sinai Hospital, US) outlines the findings of the ABILITY Global Diabetes study onsite at EuroPCR 2024.The ABILITY study (NCT04236609) aimed to evaluate the efficacy and safety of the Abluminus DES+ Sirolimus Eluting Stent System (SES) as compared to the XIENCE Everolimus Eluting Coronary Stent System in diabetic patients eligible for percutaneous coronary…
View more
Author(s):
Shigeru Saito
Added:
1 month ago
EuroPCR25 - Novel DynamX Bioadaptor demonstrates a sustained reduction of device-related events from six-month to three-year follow-up compared to drug-eluting stents (DES).We are joined by Dr Shigeru Saito (Shonan Kamakura General Hospital, Kamakura, JP) to discuss key findings from the BIOADAPTOR RCT trial (NCT04192747). This prospective, randomised controlled trial compared the ELX1805J …
View more